MedPath

Vime Anti-Scour 50 mg/ml Oral Solution

Registration Number: MAL23096031HA

Approved
Approval ID

70e45e71bea50815

Registration Number

MAL23096031HA

Registration Date

Jul 4, 2025

Regulatory Authority
NPRA
Malaysia

Product Information

Additional product specifications and packaging information as registered with NPRA Malaysia.

Product Specifications

PRODUCT SPECIFICATIONS

Official SourceNPRA Database
Available Package Types1 type
Last UpdatedJul 4, 2025

PACKAGING INFORMATION (1)

250 mlAvailable
Package Size: 250 ml
Status: NPRA Approved

Active Ingredients

Active pharmaceutical ingredients contained in this NPRA-approved product.

Ingredients (1)

Spectinomycin Dihydrochloride PentahydrateActive
Monograph: spectinomycin dihydrochloride pentahydrate

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

Vime Anti-Scour 50 mg/ml Oral Solution - NPRA Drug Approval Details | MedPath - Medical Intelligence Platform